全文获取类型
收费全文 | 36267篇 |
免费 | 3020篇 |
国内免费 | 1237篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 751篇 |
妇产科学 | 189篇 |
基础医学 | 2110篇 |
口腔科学 | 103篇 |
临床医学 | 5324篇 |
内科学 | 9662篇 |
皮肤病学 | 140篇 |
神经病学 | 773篇 |
特种医学 | 1406篇 |
外国民族医学 | 8篇 |
外科学 | 3694篇 |
综合类 | 4268篇 |
现状与发展 | 1篇 |
预防医学 | 1608篇 |
眼科学 | 253篇 |
药学 | 6426篇 |
23篇 | |
中国医学 | 1839篇 |
肿瘤学 | 1895篇 |
出版年
2024年 | 26篇 |
2023年 | 655篇 |
2022年 | 749篇 |
2021年 | 1412篇 |
2020年 | 1621篇 |
2019年 | 1622篇 |
2018年 | 1524篇 |
2017年 | 1335篇 |
2016年 | 1275篇 |
2015年 | 1343篇 |
2014年 | 2281篇 |
2013年 | 3023篇 |
2012年 | 1842篇 |
2011年 | 2037篇 |
2010年 | 1561篇 |
2009年 | 1620篇 |
2008年 | 1595篇 |
2007年 | 1623篇 |
2006年 | 1465篇 |
2005年 | 1315篇 |
2004年 | 1094篇 |
2003年 | 958篇 |
2002年 | 790篇 |
2001年 | 759篇 |
2000年 | 562篇 |
1999年 | 628篇 |
1998年 | 552篇 |
1997年 | 568篇 |
1996年 | 401篇 |
1995年 | 448篇 |
1994年 | 435篇 |
1993年 | 376篇 |
1992年 | 341篇 |
1991年 | 306篇 |
1990年 | 276篇 |
1989年 | 211篇 |
1988年 | 239篇 |
1987年 | 189篇 |
1986年 | 153篇 |
1985年 | 247篇 |
1984年 | 211篇 |
1983年 | 169篇 |
1982年 | 129篇 |
1981年 | 123篇 |
1980年 | 106篇 |
1979年 | 64篇 |
1978年 | 66篇 |
1977年 | 54篇 |
1976年 | 57篇 |
1975年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
1.
2.
Karen Kayser Ariel Washington Lesley M. Harris Barbara Head 《Journal of psychosocial oncology》2021,39(1):17-34
Abstract
Purpose
Financial hardship can be a major cause of distress among persons with cancer, resulting in chronic stress and impacting physical and emotional health. This paper provides an analysis of the lived experience of cancer patients’ financial hardship from diagnosis to post-treatment. 相似文献3.
《Clinical genitourinary cancer》2022,20(5):442-451
IntroductionSelective internal radiation therapy (SIRT) is a potential treatment of primary renal cell carcinoma (RCC) deemed unsuitable for conventional therapy. RESIRT is the first-in-human study to evaluate safety and feasibility of SIRT for primary RCC.Patients and MethodsPatients with RCC, unsuitable for, or who declined conventional therapy, were eligible. A single transfemoral micro-catheter administration of yttrium-90 (Y-90) resin microspheres (SIR-Spheres) was delivered super selectively via the renal artery to the tumour at intended radiation doses of 75, 100, 150, 200, 300 Gy and a final cohort with a procedural endpoint of “imminent stasis,” in a dose-escalation design. Post-SIRT follow-up was 12 months. Study endpoints included safety and toxicity 30-days and 12-months post-SIRT and tumour response (RECIST v1.1).ResultsIn total, 21 patients were enrolled, mean (SD) age was 75 (9.3) years, WHO performance status was 0 in 81%, 12 (57%) had stage 3 chronic kidney disease, and 7 (33%) had prior contralateral nephrectomy. Overall, 71% of patients completed 12 months of follow-up. Intended doses were delivered without any dose-limiting toxicity. Seventeen out of 21 (81%) patients experienced an adverse event (AE) from any cause within 30 days post-SIRT; all SIRT-related AEs were grade 1 to 2. Best overall tumour responses were partial response 1/21 (4.8%), stable disease 19/21 (90.5%) and progressive disease 1/21 (4.8%).ConclusionThis study demonstrated good tolerability of SIRT at all dose levels including “imminent stasis” in treating primary tumours in RCC patients otherwise unsuitable for conventional therapy. SIRT with Y-90 resin microspheres may be a feasible treatment option for RCC. 相似文献
4.
5.
6.
《Archives of Cardiovascular Diseases》2022,115(10):505-513
Central illustration: cumulative major adverse cardiac events (MACE) and bioresorbable vascular scaffold (BVS) thrombosis rates after 1, 2, 3, 4 and 5 years. 相似文献
7.
8.
《Diagnostic and interventional imaging》2020,101(6):335-345
This article was designed to provide a pediatric cardiac computed tomography angiography (CCTA) expert panel consensus based on opinions of experts of the Société Française d’Imagerie Cardiaque et Vasculaire diagnostique et interventionnelle (SFICV) and of the Filiale de Cardiologie Pédiatrique Congénitale (FCPC). This expert panel consensus includes recommendations for indications, patient preparation, CTA radiation dose reduction techniques, and post-processing techniques. The consensus was based on data from available literature (original papers, reviews and guidelines) and on opinions of a group of specialists with extensive experience in the use of CT imaging in congenital heart disease. In order to reach high potential and avoid pitfalls, CCTA in children with congenital heart disease requires training and experience. Moreover, pediatric cardiac CCTA protocols should be standardized to acquire optimal images in this population with the lowest radiation dose possible to prevent unnecessary radiation exposure. We also provided a suggested structured report and a list of acquisition protocols and technical parameters in relation to specific vendors. 相似文献
9.
目的:系统评价丹红注射液对急性心肌梗死(AMI)经皮冠状动脉介入治疗(PCI)围手术期心功能和心肌梗塞溶栓治疗(TIMI)血流分级的影响。方法:计算机检索CNKI,万方数据库,维普数据库,Pub Med,CBM,Web of Science,The Cochrane Library共7个数据库,全面采集在PCI围手术期应用丹红注射液治疗急性心梗的临床试验,采用Cochrane风险评价表进行文献质量评价,运用Revman 5.3软件进行Meta分析。结果:共纳入12个临床试验,包含1131例患者,其中丹红治疗组569例,对照组562例,结果显示在常规治疗的基础上加入丹红注射液治疗,患者的左室射血分数明显增高[均数差(MD)=6.62,95%可信区间(CI)(4.91,8.34),P<0.00001],TIMI分级3级患者明显增多[相对危险度(RR)=0.22,95%CI(0.12,0.41),P<0.00001],脑利钠肽水平明显降低[MD=-151.86,95%CI(-247.00,-56.72),P=0.002]。结论:丹红注射液可以提高急性心梗PCI围手术期心功能和增加TIMI血流的分级。 相似文献
10.
目的探讨胸痹心痛病患者的中医心脏康复护理意义。方法选取2018年1月-2019年1月在大连中医医院内一病房就诊的80例胸痹心痛病患者,经辨证分型为气虚血瘀型胸痹,随机分为试验组和对照组,对照组40例采取常规护理,试验组40例在对照组的基础上使用中医心脏康复护理,主要包括:证候施护、饮食护理、中医特色技术、情志护理、健康指导等。通过中医证候评分对治疗的有效率进行观察。结果试验组有效率为92.5%,对照组有效率为77.5%,试验组优于对照组,差异有统计学意义(P<0.05)。结论对胸痹心痛病患者的中医心脏康复护理,可以有效提高临床有效率,改善临床症状,提高患者生活质量,值得在临床推广。 相似文献